Qingdao Gon Technology Co., Ltd. Overview
Gon Technology is a Qingdao-based, founder-controlled Chinese materials group that has built a vertically integrated chain running from monomers through synthetic resins (notably polystyrene) to modified polymer materials, polymer composites and finished components for automotive, home-appliance and new-energy-vehicle customers. According to its Hong Kong prospectus, it was China's second-largest producer of modified and composite polymer materials in 2024 with a 2.5% share [S7], China's largest polystyrene enterprise by capacity and the second-largest bone-gelatin producer [S11]. A second "wing" — biomedical and health — is anchored by its ChiNext-listed subsidiary Dongbao Bio (gelatin, collagen, hollow capsules). Revenue reached RMB 21.25bn in FY2025 [S12], and H1 2026 attributable profit rose 89% on upstream integration gains [S13]. In July 2026 management declared a third pillar — AI compute infrastructure and embodied-intelligence robotics — reframing Gon as a "high-end manufacturing + green compute + AI" platform, a pivot that materially raises its capital intensity and execution risk [S13][S19].
Company's own description. The HKEX company profile describes the principal business as R&D, production and sale of new chemical materials — green petrochemical new materials, organic polymer modified materials and organic polymer composite materials — plus R&D, production and sale of natural collagen and collagen-based products, including gelatin, collagen and derivatives, and hollow capsules [S5]. The IPO due-diligence summary adds that the group also operates a Health Industry segment and a Property Investment segment [S6].
Integrated value chain. Management frames the chemicals business as a full chain of "monomer → synthetic resin → organic polymer modification/composite materials → finished products" [S13]. The 2026 interim report lists the chain-extension projects underpinning this: a propylene-oxide (PO) co-production project, Gon Polymer's 1,000,000 t/yr polystyrene project, Hong Kong Petrochemical's 250,000 t/yr high-performance PS project, Rizhao Gon's 120,000 t/yr expandable PS (EPS) project, and a Jiangsu Guoheng project [S4].
Revenue model. Revenue is overwhelmingly product sales (B2B, contract and spot) rather than services, subscriptions or licensing. There is no disclosed licensing revenue; property investment income is minor and not separately quantified in the sources reviewed.
Customer types and end-markets. Industrial customers in automotive (including NEV battery-pack components, which management says reached volume production in 2026 [S16]), home appliances, packaging/insulation (EPS), electronics, and pharmaceuticals/nutraceuticals (capsules, gelatin, collagen) [S11]. Overseas revenue is small: RMB 303m in FY2025 (1.42% of total), rising to RMB 247m in H1 2026 (2.14%, +57.62% YoY) [S14].
Independent characterisation. Gon is best understood as a cost-advantaged, volume-driven converter that has spent 2022–2025 moving upstream to capture resin margins. The upstream "green petrochemical" line has gone from RMB 1.20bn of revenue in 2022 to RMB 5.29bn in 2025 [S19], and in H1 2026 its gross margin jumped by 7.30 points to 12.15% [S14] — the single largest driver of the profit inflection. The health wing provides diversification but is a small and lower-growth contributor. The July 2026 AI-compute pivot is a strategic departure rather than an adjacency, and it is too early to model.
Strategy
Stated strategy (FY2025 AR). Gon positions itself as a vertically integrated industrial platform with chemical new materials and biomedical/health as its "two wings". Its key moves are a precision "New Materials+" layout, a "Collagen+" upgrade, M&A of upstream raw materials, and the H-share listing as a globalisation capital base [S14].
Strategic shift (H1 2026 report). Management now describes a three-pillar "high-end manufacturing + green compute + AI" platform. AI compute construction/operations and robotics form the third growth pillar [S13]. The FY2025 AR had envisaged compute only as an in-house centre for robot training; the upgrade to a standalone pillar came faster than planned [S14].
Initiatives in the last 24 months
IPO use of proceeds: R&D, capacity expansion, brand promotion and strategic acquisitions [S11]. No numeric medium-term financial targets have been published. ESG targets are not publicly disclosed in sources reviewed.
Products & Services
Pricing models are not publicly disclosed. Materials are priced on commodity-linked, cost-plus terms (standard industry practice; not company-specific disclosure).
Product Portfolio
| Segment | Product line | Description / capabilities | Target customers | Status / scale | Source |
|---|---|---|---|---|---|
Green petrochemical | Polystyrene (GPPS/HIPS) | Commodity and high-performance PS resins; group claims China's largest PS capacity | Appliances, packaging, electronics | Gon Polymer 1,000,000 t/yr project; Hong Kong Petrochemical 250,000 t/yr high-performance PS | [S4][S11] |
Green petrochemical | Expandable polystyrene (EPS) | Foamable beads for insulation and protective packaging | Construction, packaging | Rizhao Gon 120,000 t/yr | [S4] |
Green petrochemical | Propylene oxide (PO) co-production | Upstream monomer/intermediate | Internal and external polyol/chemical users | Project disclosed; capacity not stated in sources reviewed | [S4] |
Green petrochemical (planned) | High-purity dianhydride monomer, polyimide, high-purity p-methylstyrene | Upstream specialty monomers and high-performance polymers | Electronics, specialty materials | Under planning (Jul 2026) | [S16] |
Modified materials | Modified engineering and general plastics | Compounded PP/ABS/PS/PC grades with flame-retardant, reinforced and weatherable properties (grade detail not disclosed) | Auto OEMs/Tier-1s, appliance makers | Largest revenue line, RMB 10.36bn in FY2025 | [S14] |
Composite materials | Polymer composites and parts | Fibre-reinforced and composite components | Automotive, NEV | RMB 3.92bn in FY2025 | [S14] |
Composite materials | NEV battery-pack products | Composite battery enclosures/components | NEV makers | Volume ramp in 2026 | [S16] |
Health | Gelatin (incl. bone gelatin) | Pharmaceutical and food gelatin; group claims #2 bone-gelatin producer in China | Pharma, food | Via Dongbao Bio | [S5][S11] |
Health | Collagen and derivatives | Collagen peptides and consumer health products | Nutraceutical, consumer | Via Dongbao Bio | [S5] |
Health | Hollow (empty) capsules | Gelatin hard capsules | Pharma, nutraceutical | Via group health businesses | [S5] |
Health | Consumer nutrition range | Health foods, nutritional proteins, gut-health, weight-management and beauty products | Consumers | Disclosed in 2022 annual report | [S15] |
Property | Property investment | Leasing income | — | Minor; not quantified | [S6] |
AI/Robotics (new) | Green compute / intelligent computing centres | Compute hardware, AI data centres, green-power coordination | Enterprise/AI customers | Gon Jiuchi (Shanghai) formed Jul 2026 | [S19] |
AI/Robotics (new) | Biped and quadruped robots | Biped with high-torque lightweight servo joint modules, under 45 kg | Industrial/scene applications | R&D prototypes (May 2026) | [S16] |
AI/Robotics (new) | E-skin, force-feedback teleoperation gloves | Sensing and teleoperation hardware | Robotics developers | Disclosed in H1 2026 report | [S16] |
Financial Narrative
Income statement (RMB million)
FY2021 growth computed against FY2020 revenue of RMB 7.18bn and NP of RMB 731m [S15]. Revenue CAGR FY2021–FY2025: ≈21.5% (computed). Gross profit, operating income and EBITDA for full years were not disclosed in the sources reviewed.
Interim/quarterly trend (RMB million)
Sources: [S20][S23][S13][S19][S25]. H1 EPS is adjusted for the June 2026 4.8-for-10 bonus issue [S4]; Q1 EPS is pre-bonus. H1 2025 operating profit derived from the +100.82% growth rate.
Balance sheet (RMB million)
Source: [S15]: As at 30 June 2026 [S19][S27]:
Goodwill and intangibles, working capital, capex, FCF, buybacks executed, ROIC, interest coverage and cash conversion cycle were not publicly disclosed in sources reviewed. Operating cash flow per share was RMB 0.69 in Q1 2025 and RMB 0.44 in Q1 2026 (-36%) [S20][S23]. Book value per share was RMB 22.89 at Q1 2026 [S23].
Commentary. Three phases are visible.
FY2021–FY2023: scale without profit: Revenue more than doubled, but attributable profit fell from RMB 731m (FY2020) to RMB 471m (FY2023) as the group added low-margin upstream PS volume and absorbed acquisitions. Net margin compressed from roughly 10% to 2.7%.
FY2024–FY2025: recovery: Profit recovered on mix and modified-materials margin expansion (+2.80 points in FY2025), with ROE reaching 15.72%.
H1 2026: inflection: Upstream PS margins more than doubled, and the modified line saw both volume and price gains, lifting half-year net margin to 6.29% and annualised ROE to around 20%. Management explicitly attributes the gain to full-chain synergy [S25].
Two cautions apply. Operating cash flow lagged profit in Q1 2026, and receivables were flagged as large historically (Q1 2025 receivables were 412% of annual NP [S20]). Leverage is also rising into the compute pivot.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Revenue by Segment
| Segment (CNY Mn) | FY2022 | FY2024 | FY2025 |
|---|---|---|---|
Green petrochemical & new materials | 1,196 | 3,869 | 5,290 |
Organic polymer modified materials | — | 10,325 | 10,357 |
Organic polymer composite materials | — | 3,175 | 3,917 |
Health, property & other (residual) | — | 1,818 | 1,687 |
Total revenue | 13,406 | 19,188 | 21,251 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansSegment YoY growth (%)
| Segment YoY growth (%) | FY2025 | H1 2026 |
|---|---|---|
Green petrochemical & new materials | 36.72 | 47.14 |
Organic polymer modified materials | 0.31 | 11.57 |
Organic polymer composite materials | 23.36 | 18.48 |
Segment gross margin (%)
| Segment gross margin (%) | FY2024 | FY2025 |
|---|---|---|
Green petrochemical & new materials | 4.84 | 5.84 |
Organic polymer modified materials | 9.36 | 12.16 |
Organic polymer composite materials | 9.26 | 12.81 |
Revenue by Segment (Half-Yearly)
| Segment (CNY Mn) | H1 2025 | H1 2026 |
|---|---|---|
Green petrochemical & new materials | 1,961 | 2,886 |
Organic polymer modified materials | 4,914 | 5,483 |
Organic polymer composite materials | 1,727 | 2,046 |
Total revenue | 9,754 | 11,514 |
Segment gross margin (%) (Half-Yearly)
| Segment gross margin (%) | H1 2025 | H1 2026 |
|---|---|---|
Green petrochemical & new materials | 4.85 | 12.15 |
Organic polymer modified materials | 11.73 | 14.02 |
Organic polymer composite materials | 11.81 | 14.46 |
Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue (as originally reported) | 9,766.0 | 13,406.4 | 17,438.8 | 19,187.5 | 21,251.0 |
Revenue (restated basis, aggregator) | — | — | 17,439 | 19,220 | 21,251 |
Pre-tax profit (as reported) | — | — | 577.9 | 797.1 | — |
Total profit (aggregator series) | — | — | 570 | 785 | 947 |
Attributable net profit (as reported) | 642.9 | 663.1 | 471.5 | 685.2 | 841.0 |
Attributable net profit (restated basis) | — | — | 466 | 676 | 841 |
Recurring NP excl. non-recurring | 630.1 | 630.6 | — | — | — |
Basic EPS (MYR Bn, pre-bonus basis) | 2.37 | 2.44 | 1.72 | 2.52 | 3.17 |
DPS cash (MYR Bn) | — | 0.25 | — | — | 0.50 |
Growth & margins (%)
| Growth & margins (%) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue growth | 35.99 | 37.28 | 30.08 | 10.03 | 10.57 |
Attributable NP growth | -12.03 | 3.14 | -28.89 | 45.33 | 24.38 |
Attributable net margin | 6.58 | 4.95 | 2.70 | 3.57 | 3.96 |
Weighted ROE | — | — | — | — | 15.72 |
Margin Analysis (%) and Per-Share Data
| Metric | Q1 2025 | Q1 2026 | H1 2025 | H1 2026 |
|---|---|---|---|---|
Revenue | 4,412 | 5,377 | 9,754 | 11,514 |
Attributable net profit | 111 | 257 | 345.9 | 655 |
Operating profit | — | — | 385 | 774 |
Gross margin (%) | 8.81 | 11.93 | — | — |
Net margin (%) | 2.58 | 5.05 | 3.56 | 6.29 |
Basic EPS (MYR Bn) | 0.42 | 0.93 | 0.88 | 1.53 |
Financial Analysis
| Metric | FY2020 | FY2021 | FY2022 |
|---|---|---|---|
Total assets | 5,461.5 | 9,908.9 | 12,753.1 |
Equity attributable to shareholders | 3,097.7 | 3,476.0 | 4,072.1 |
Financial Analysis — Monetary funds
| Metric | Value (CNY Mn) |
|---|---|
Monetary funds (货币资金) | 4,018 |
Cash and cash equivalents | 2,018 |
Short-term borrowings | 1,819 |
Long-term borrowings | 3,410 |
Non-current liabilities due within one year | 1,358 |
Gross interest-bearing debt (sum of the above three) | 6,587 |
Net debt vs monetary funds | 2,569 |
Net assets | 9,155 |
Guarantees to subsidiaries outstanding | 4,795 |
Revenue by Region
| Region (CNY Mn) | FY2024 | FY2025 |
|---|---|---|
Overseas | 304 | 303 |
Mainland China (derived) | 18,884 | 20,948 |
Revenue by Region (Half-Yearly)
| Region (CNY Mn) | H1 2025 | H1 2026 |
|---|---|---|
Overseas | 157 | 247 |
Mainland China (derived) | 9,597 | 11,267 |
Share Price
| Metric | IPO (4 Feb 2026) | Debut midday | 20 Sep 2026 |
|---|---|---|---|
H-share price (HKD) | 36.00 | 41.78 | 41.60 |
Income Statement and Per-Share Data
| Metric | FY2025A | FY2026E | FY2027E | FY2028E |
|---|---|---|---|---|
Revenue (CNY Mn) | 21,251 | 25,991 | 30,105 | 38,087 |
Net profit (CNY Mn) | 841 | 1,177 | 1,486 | 1,972 |
EPS (MYR Bn, post-bonus) | — | 2.68 | 3.38 | 4.50 |
Broker | Date | FY2026E NP (RMB M) | FY2027E NP (RMB M) | — |
China Galaxy | 31 Aug 2026 | 1,265 | 1,520 | — |
Founder Securities | 28 Aug 2026 | 1,208 | 1,513 | — |
Dongguan Securities | 30 Mar 2026 | 923 | 1,045 | — |
Analyst Conclusions
Guidance. No formal numeric guidance has been issued. The H1 2026 profit alert range of RMB 600–750m was met at RMB 655m [S25][S13]. Consensus expects FY2026 NP of RMB 1.18bn (+40%) and revenue of RMB 26.0bn (+22%) [S26]. H1 2026 already represents 56% of that profit consensus.
Bull case
-
Upstream integration is structural: green petrochemical GM rose from 4.85% to 12.15% YoY while volumes grew 47% [S14].
-
Modified materials have re-accelerated (+11.57% in H1 2026 versus +0.31% in FY2025) with margin gains, and NEV battery-pack composites add a new growth vector [S14][S16].
-
A 15.7% ROE (FY2025), rising toward 20% annualised, at an aggregator TTM EPS of 2.65 offers earnings momentum with dual-market liquidity [S12][S8].
Bear case
-
Up to RMB 15bn of guarantees for an unproven AI-compute venture (1.64x net assets) risks capital destruction and a de-rating [S19].
-
Liquidity is tight: RMB 6.59bn of gross debt and RMB 4.80bn of existing guarantees against RMB 4.02bn of monetary funds, with weakening operating cash flow [S27][S23].
-
PS spreads are cyclical; FY2023 showed profit can fall nearly 30% despite revenue growth of 30% [S5].
Catalysts and monitorables (next 12 months). Q3 2026 results (late October); approval and drawdown of the Gon Jiuchi guarantee and the first compute capex; PS/PO project commissioning; NEV battery-pack volumes; operating cash flow versus profit; FY2026 dividend policy; any credit facility or bond issuance; and H-share index inclusion.
Analyst verdict. Gon Technology enters late 2026 with the best operating momentum in its history. A decade-long effort to integrate upstream into polystyrene and monomers is finally showing up in margins. H1 2026 net margin of 6.29% is almost double the prior-year 3.56% [S19], and the improvement is broad-based across all three chemical lines rather than a one-off gain. If FY2026 lands near the RMB 1.18bn consensus, earnings will have grown roughly 2.5x from the FY2023 trough in three years. The February 2026 H-share listing broadened the shareholder base and drew exceptional retail demand, and Stock Connect inclusion supports liquidity.
The investment case has, however, been complicated by management's own strategy. The July 2026 decision to make AI compute and robotics a third pillar, backed by a proposed guarantee capacity of up to RMB 15bn, introduces a binary capital-allocation risk into what had become a clean margin-recovery story. Gon has no disclosed competitive edge in data-centre operations. Its balance sheet already carries more short-dated debt and subsidiary guarantees than cash. Large-scale compute capex would push leverage materially higher just as the commodity cycle could turn.
Our synthesis: the core materials franchise appears undervalued on its own merits, provided the PS spread holds. The equity, however, will increasingly trade on investors' confidence in management's discipline around the compute venture. We would treat the stock as a positive-momentum but governance-sensitive holding. The key monitorables are the scale and financing structure of Gon Jiuchi's first projects, cash conversion, and whether the founder-controlled board sets explicit return hurdles. Clear ring-fencing of the compute business — for example via external partners or project finance — would materially de-risk the thesis. Open-ended parent guarantees would justify a governance discount despite strong operating results.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Notes |
|---|---|---|
Wang Aiguo (王愛國) | Chairman & General Manager | Founder and controlling shareholder; also legal representative of Dongbao Bio |
Li Zonghao (李宗好) | Executive Director | — |
Li Huiying (李慧穎) | Executive Director | — |
Han Bo (韓博) | Executive Director | — |
Wang Yaping (王亞平) | Independent Non-Executive Director | — |
Sun Jianqiang (孫建強) | Independent Non-Executive Director | — |
Xiang Ting (項婷) | Independent Non-Executive Director | — |
Yu Chuibai (于垂柏) | Head of accounting (as of 2022 AR) | — |
Major Shareholders
| Holder | Shares | Class | % of total | % of class |
|---|---|---|---|---|
Wang Aiguo and connected persons | 153,000,000 | A | 50.79 | 56.41 |
First Seafront Fund Series SPC | 3,055,400 | H | 1.04 | 10.18 |
Zhou Wanyuan | 2,361,000 | H | 0.80 | 7.87 |
SLD International Enterprises Ltd | 2,222,200 | H | 0.75 | 7.41 |
Competitive Landscape
Competitors by Segment
| Segment | Named competitors (not exhaustive) |
|---|---|
Modified plastics / composites (China) | Kingfa Sci & Tech (600143.SH), Shanghai Pret Composites (002324.SZ), Shenzhen Wote Advanced Materials (002886.SZ), Guangdong Silver Age Sci & Tech (300221.SZ), Polyrocks Chemical (688669.SH) |
Polystyrene / EPS | Sinopec and CNPC affiliates; foreign-invested and private PS producers in East and South China |
Gelatin / collagen | Rousselot (Darling Ingredients), Gelita, PB Leiner (Tessenderlo), Nitta Gelatin |
Hard capsules | Lonza Capsugel, ACG, Suheung |
Competitor Detail
| Metric (FY2025) | Gon |
|---|---|
Revenue (CNY Mn) | 21,251 |
Revenue growth (%) | 10.57 |
Attributable net margin (%) | 3.96 |
ROE (%) | 15.72 |



